Blood lead below 0.48 μmol/L (10 μg/dL) and mortality among US adults

Circulation

Volumn 114, Issue 13, 2006, Pages 1388-1394

  Menke, Andy ^a   Muntner, Paul ^a,b   Batuman, Vecihi ^b   Silbergeld, Ellen K ^c   Guallar, Eliseo ^d  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c The Johns Hopkins University   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular diseases; Mortality; Myocardial infarction; Risk factors; Stroke

Indexed keywords

ADULT; ARTICLE; CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; LEAD BLOOD LEVEL; MALE; MEDICAL EXAMINATION; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; STROKE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; LEAD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SAMPLING STUDIES; UNITED STATES;

EID: 33749005641     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.628321     Document Type: Article

References (31)

1. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med. 2002;162:2443-2449.
2. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med. 2005;165:2155-2161.
3. Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD. The decline in blood lead levels in the United States: the National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994;272:284-291.
4. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Washington, DC: US Dept of Health & Human Services; 1994:1. Publication No. 94-1308.
5. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920-929.
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470.
7. Gunter EW, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atlanta, Ga: US Dept of Health & Human Services; 1996:VII-H-1-VII-H-21.
8. Sassa S, Granick JL, Granick S, Kappas A, Levere RD. Studies in lead poisoning, I: microanalysis of erythrocyte protoporphyrin levels by spectrophotometry in the detection of chronic lead intoxication in the subclinical range. Biochem Med. 1973;8:135-148.
9. Pocock SJ, Shaper AG, Ashby D, Delves HT, Clayton BE. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect. 1988;78:23-30.
10. Muntner P, He J, Vupputuri S, Coresh J, Batuman V. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int. 2003;63:1044-1050.
11. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004;109:3196-3201.
12. Nordberg M, Winblad B, Fratiglioni L, Basun H. Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population-based study. Am J Ind Med. 2000;38:290-294.
13. Telisman S, Jurasovic J, Pizent A, Cvitkovic P. Blood pressure in relation to biomarkers of lead, cadmium, copper, zinc, and selenium in men without occupational exposure to metals. Environ Res. 2001;87:57-68.
14. Vupputuri S, He J, Muntner P, Bazzano LA, Whelton PK, Batuman V. Blood lead level is associated with elevated blood pressure in blacks. Hypertension. 2003;41:463-468.
15. Staessen JA, Lauwerys RR, Bulpitt CJ, Fagard R, Linjen P, Roels H, Thijs L, Amery A. Is a positive association between lead exposure and blood pressure supported by animal experiments? Curr Opin Nephrol Hypertens. 1994;3:257-263.
16. Victery W. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ Health Perspect. 1988;78:71-76.
17. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol. 2001;153:164-171.
18. Payton M, Hu H, Sparrow D, Weiss ST. Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol. 1994;140:821-829.
19. Weaver VM, Lee BK, Todd AC, Jaar BG, Ahn KD, Wen J, Shi W, Parsons PJ, Schwartz BS. Associations of patella lead and other lead biomarkers with renal function in lead workers. J Occup Environ Med. 2005;47:235-243.
20. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension. 1997;30:1487-1492.
21. Gonick HC. Lead, renal disease and hypertension. Am J Kidney Dis. 2002;40:202-204.
22. Lustberg ME, Schwartz BS, Lee BK, Todd AC, Silbergeld EK. The G(894)-T(894) polymorphism in the gene for endothelial nitric oxide synthase and blood pressure in lead-exposed workers from Korea. J Occup Environ Med. 2004;46:584-590.
23. Ni Z, Hou S, Barton CH, Vaziri ND. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney Int. 2004;66:2329-2336.
24. Chang HR, Tsao DA, Yu HS, Ho CK. Beta-adrenergic receptor density and adenylate cyclase activity in lead-exposed rat brain after cessation of lead exposure. Arch Toxicol. 2005;79:1-6.
25. Boscolo P, Carmignani M, Sacchettoni-Logroscino G, Rannelletti FO, Artese L, Preziosi P. Ultrastructure of the testis in rats with blood hypertension induced by long-term lead exposure. Toxicol Lett. 1988;41:129-137.
26. Batuman V. Lead nephropathy, gout, and hypertension. Am J Med Sci. 1993;305:241-247.
27. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, Rotnitzky A. The relationship of bone and blood lead to hypertension: the Normative Aging Study. JAMA. 1996;275:1171-1176.
28. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health. 1995;50:31-37.
29. Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, Todd AC, Schwartz BS. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2001;109:383-389.
30. United Nations Environment Programme, International Labour Organisation, and World Health Organization. International Program on Chemical Safety (IPCS): Inorganic Lead [IPCS INCHEM Web site]. Available at: http://www.inchem.org/ documents/ehc/ehc/ehc165.htm. 1995. Geneva, Switzerland: World Health Organization; 1995. Accessed February 21, 2006.
31. Flegal AR, Smith DR. Lead levels in preindustrial humans. N Engl J Med. 1992;326:1293-1294.